Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

A remarkable pattern of a tibial plateau fracture - use of a safe technique with practical advantages in the surgical field.

Touloupakis G, Ghirardelli S, Biancardi E, Bibiano L, Antonini G, Crippa C.

Acta Biomed. 2019 May 23;90(2):343-347. doi: 10.23750/abm.v90i2.6661.

PMID:
31125017
2.

Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome.

Cattaneo C, Gramegna D, Malagola M, Pagani C, Borlenghi E, Cerqui E, Passi A, Sciumé M, Bernardi S, Crippa C, Dalceggio D, Carbone C, Pelizzari AM, Re A, Russo D, Rossi G.

Leuk Lymphoma. 2019 May 23:1-7. doi: 10.1080/10428194.2019.1613535. [Epub ahead of print]

PMID:
31120311
3.

Plate fixation in periprosthetic femur fractures Vancouver type B1: preliminary report of macroscopic evaluation of the cement mantle and short literature review.

Bibiano L, Stamboltsyan G, Touloupakis G, Ghirardelli S, Biancardi E, Longo GEG, Antonini G, Crippa C.

Acta Biomed. 2019 Jan 24;90(1):31-36. doi: 10.23750/abm.v90i1.6544.

4.

Exploring the difficulties to improve minimally invasive application with long PHILOS plate in multifocal metadiaphyseal fractures of the proximal humerus: analysis of intraoperative procedure and clinical outcomes.

Touloupakis G, Di Giorgio L, Bibiano L, Biancardi E, Ghirardelli S, Dell'Orfano M, Sinno E, Cera G, Antonini G, Crippa C.

Acta Biomed. 2019 Jan 15;89(4):532-539. doi: 10.23750/abm.v89i4.6212.

5.

Preliminary report of the characteristics of the upper thigh spur area of the femoral neck in Garden I and II subcapital fractures.

Touloupakis G, Maione A, Lettera MG, Stuflesser W, Ferrara F, Antonini G, Crippa C.

Acta Biomed. 2018 Jun 15;89(2):249-254. doi: 10.23750/abm.v89i2.5660.

6.

Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysis.

Cerrato C, Di Raimondo F, De Paoli L, Spada S, Patriarca F, Crippa C, Mina R, Guglielmelli T, Ben-Yehuda D, Oddolo D, Nozzoli C, Angelucci E, Cascavilla N, Rizzi R, Rocco S, Baldini L, Ponticelli E, Marcatti M, Cangialosi C, Caravita T, Benevolo G, Ria R, Nagler A, Musto P, Tacchetti P, Corradini P, Offidani M, Palumbo A, Petrucci MT, Boccadoro M, Gay F.

J Cancer Res Clin Oncol. 2018 Jul;144(7):1357-1366. doi: 10.1007/s00432-018-2641-5. Epub 2018 Apr 19.

PMID:
29675792
7.

Early-stage radiological critical analysis of unsuccessful cases following a four-part fracture osteosynthesis of the proximal humerus: focus on the "P" sign.

Touloupakis G, Stuflesser W, Ferrara F, Maione A, Antonini G, Crippa C.

Acta Biomed. 2017 Aug 23;88(2):178-184. doi: 10.23750/abm.v88i2.5295.

8.

Vascular Injury Due to Humerus Fracture in Pediatric Age: When the Treatment Is Mandatory.

Salvati S, Settembrini AM, Bissacco D, Dallatana R, Mazzaccaro D, Crippa C, Romano P, Settembrini P.

Ann Vasc Surg. 2017 Oct;44:420.e11-420.e15. doi: 10.1016/j.avsg.2017.03.184. Epub 2017 May 4.

PMID:
28479469
9.

A distal-lock electromagnetic targeting device for intramedullary nailing: Suggestions and clinical experience.

Antonini G, Stuflesser W, Crippa C, Touloupakis G.

Chin J Traumatol. 2016 Dec 1;19(6):358-361.

10.

A rare combined injury of dorsal fracture-dislocation of four carpometacarpal joints and trapezium, trapezoid and distal radius bone fractures.

Touloupakis G, Stuflesser W, Antonini G, Ferrara F, Crippa C, Lettera MG.

Acta Biomed. 2016 May 6;87(1):101-5.

PMID:
27163903
11.

Nutrition education intervention for women with breast cancer: effect on nutritional factors and oxidative stress.

Schiavon CC, Vieira FG, Ceccatto V, de Liz S, Cardoso AL, Sabel C, Gonzalez-Chica DA, da Silva EL, Galvan D, Crippa CG, Di Pietro PF.

J Nutr Educ Behav. 2015 Jan-Feb;47(1):2-9. doi: 10.1016/j.jneb.2014.09.005.

PMID:
25528078
12.

Autologous transplantation and maintenance therapy in multiple myeloma.

Palumbo A, Cavallo F, Gay F, Di Raimondo F, Ben Yehuda D, Petrucci MT, Pezzatti S, Caravita T, Cerrato C, Ribakovsky E, Genuardi M, Cafro A, Marcatti M, Catalano L, Offidani M, Carella AM, Zamagni E, Patriarca F, Musto P, Evangelista A, Ciccone G, Omedé P, Crippa C, Corradini P, Nagler A, Boccadoro M, Cavo M.

N Engl J Med. 2014 Sep 4;371(10):895-905. doi: 10.1056/NEJMoa1402888.

13.

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival.

Ferrero S, Ladetto M, Drandi D, Cavallo F, Genuardi E, Urbano M, Caltagirone S, Grasso M, Rossini F, Guglielmelli T, Cangialosi C, Liberati AM, Callea V, Carovita T, Crippa C, De Rosa L, Pisani F, Falcone AP, Pregno P, Oliva S, Terragna C, Musto P, Passera R, Boccadoro M, Palumbo A.

Leukemia. 2015 Mar;29(3):689-95. doi: 10.1038/leu.2014.219. Epub 2014 Jul 16.

PMID:
25027515
14.

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib.

Gambella M, Rocci A, Passera R, Gay F, Omedè P, Crippa C, Corradini P, Romano A, Rossi D, Ladetto M, Boccadoro M, Palumbo A.

Haematologica. 2014 Feb;99(2):e14-6. doi: 10.3324/haematol.2013.090142. No abstract available.

15.

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study.

Larocca A, Montefusco V, Bringhen S, Rossi D, Crippa C, Mina R, Galli M, Marcatti M, La Verde G, Giuliani N, Magarotto V, Guglielmelli T, Rota-Scalabrini D, Omedé P, Santagostino A, Baldi I, Carella AM, Boccadoro M, Corradini P, Palumbo A.

Blood. 2013 Oct 17;122(16):2799-806. doi: 10.1182/blood-2013-03-488676. Epub 2013 Aug 16.

16.

Increased body weight and blood oxidative stress in breast cancer patients after adjuvant chemotherapy.

Galvan D, Pietro PF, Vieira FG, Ambrosi C, Cesa C, Cardoso AL, Cavalcante Lda S, Crippa CG, Silva EL.

Breast J. 2013 Sep-Oct;19(5):555-7. doi: 10.1111/tbj.12165. Epub 2013 Jul 29. No abstract available.

PMID:
23895736
17.

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results.

Gay F, Magarotto V, Crippa C, Pescosta N, Guglielmelli T, Cavallo F, Pezzatti S, Ferrari S, Liberati AM, Oliva S, Patriarca F, Offidani M, Omedé P, Montefusco V, Petrucci MT, Giuliani N, Passera R, Pietrantuono G, Boccadoro M, Corradini P, Palumbo A.

Blood. 2013 Aug 22;122(8):1376-83. doi: 10.1182/blood-2013-02-483073. Epub 2013 Jun 17. Erratum in: Blood. 2014 Jun 12;123(24):3843.

18.

Characteristics of newly diagnosed women with breast cancer: a comparison with the recommendations of the WCRF/AICR Second Report.

Ceccatto V, Cesa C, Kunradi Vieira FG, Altenburg de Assis MA, Crippa CG, Faria Di Pietro P.

Nutr Hosp. 2012 Nov-Dec;27(6):1973-80. doi: 10.3305/nh.2012.27.6.6006.

PMID:
23588447
19.

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.

Cavo M, Pantani L, Petrucci MT, Patriarca F, Zamagni E, Donnarumma D, Crippa C, Boccadoro M, Perrone G, Falcone A, Nozzoli C, Zambello R, Masini L, Furlan A, Brioli A, Derudas D, Ballanti S, Dessanti ML, De Stefano V, Carella AM, Marcatti M, Nozza A, Ferrara F, Callea V, Califano C, Pezzi A, Baraldi A, Grasso M, Musto P, Palumbo A; GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Italian Myeloma Network.

Blood. 2012 Jul 5;120(1):9-19. doi: 10.1182/blood-2012-02-408898. Epub 2012 Apr 12.

20.

Dietary intake and oxidative stress in breast cancer: before and after treatments.

Rockenbach G, Di Pietro PF, Ambrosi C, Boaventura BC, Vieira FG, Crippa CG, Da Silva EL, Fausto MA.

Nutr Hosp. 2011 Jul-Aug;26(4):737-44. doi: 10.1590/S0212-16112011000400011.

PMID:
22470018
21.

Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma.

Corso A, Galli M, Mangiacavalli S, Rossini F, Nozza A, Pascutto C, Montefusco V, Baldini L, Cafro AM, Crippa C, Cazzola M, Corradini P.

Am J Hematol. 2012 Feb;87(2):150-4. doi: 10.1002/ajh.22220. Epub 2011 Dec 21.

22.

[Factors associated with changes in energy intake of women after treatment for breast cancer].

Ambrosi C, Di Pietro PF, Rockenbach G, Vieira FG, Galvan D, Crippa CG, Fausto MA.

Rev Bras Ginecol Obstet. 2011 Aug;33(8):207-13. Portuguese.

PMID:
22159622
23.

Factors associated with oxidative stress in women with breast cancer.

Vieira FG, Di Pietro PF, Boaventura BC, Ambrosi C, Rockenbach G, Fausto MA, Crippa CG, Da Silva EL.

Nutr Hosp. 2011 May-Jun;26(3):528-36. doi: 10.1590/S0212-16112011000300015.

PMID:
21892571
24.

Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.

Larocca A, Cavallo F, Bringhen S, Di Raimondo F, Falanga A, Evangelista A, Cavalli M, Stanevsky A, Corradini P, Pezzatti S, Patriarca F, Cavo M, Peccatori J, Catalano L, Carella AM, Cafro AM, Siniscalchi A, Crippa C, Petrucci MT, Yehuda DB, Beggiato E, Di Toritto TC, Boccadoro M, Nagler A, Palumbo A.

Blood. 2012 Jan 26;119(4):933-9; quiz 1093. doi: 10.1182/blood-2011-03-344333. Epub 2011 Aug 11.

25.

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy.

Cavallo F, Bringhen S, Milone G, Ben-Yehuda D, Nagler A, Calabrese E, Cascavilla N, Montefusco V, Lupo B, Liberati AM, Crippa C, Rossini F, Passera R, Patriarca F, Cafro AM, Omedè P, Carella AM, Peccatori J, Catalano L, Caravita T, Musto P, Petrucci MT, Boccadoro M, Palumbo A.

Leukemia. 2011 Oct;25(10):1627-31. doi: 10.1038/leu.2011.131. Epub 2011 Jun 3.

PMID:
21637283
26.

Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant.

Spina F, Montefusco V, Crippa C, Citro A, Sammassimo S, Olivero B, Gentili S, Galli M, Guglielmelli T, Rossi D, Falcone AP, Grasso M, Patriarca F, De Muro M, Corradini P.

Leuk Lymphoma. 2011 Jul;52(7):1262-70. doi: 10.3109/10428194.2011.564695. Epub 2011 May 3.

PMID:
21534872
27.

Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.

Palumbo A, Cavo M, Bringhen S, Zamagni E, Romano A, Patriarca F, Rossi D, Gentilini F, Crippa C, Galli M, Nozzoli C, Ria R, Marasca R, Montefusco V, Baldini L, Elice F, Callea V, Pulini S, Carella AM, Zambello R, Benevolo G, Magarotto V, Tacchetti P, Pescosta N, Cellini C, Polloni C, Evangelista A, Caravita T, Morabito F, Offidani M, Tosi P, Boccadoro M.

J Clin Oncol. 2011 Mar 10;29(8):986-93. doi: 10.1200/JCO.2010.31.6844. Epub 2011 Jan 31.

PMID:
21282540
28.

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study.

Cavo M, Tacchetti P, Patriarca F, Petrucci MT, Pantani L, Galli M, Di Raimondo F, Crippa C, Zamagni E, Palumbo A, Offidani M, Corradini P, Narni F, Spadano A, Pescosta N, Deliliers GL, Ledda A, Cellini C, Caravita T, Tosi P, Baccarani M; GIMEMA Italian Myeloma Network.

Lancet. 2010 Dec 18;376(9758):2075-85. doi: 10.1016/S0140-6736(10)61424-9. Epub 2010 Dec 9. Erratum in: Lancet. 2011 Nov 26;378(9806):1846.

PMID:
21146205
29.

Major tumor shrinking and persistent molecular remissions after consolidation with bortezomib, thalidomide, and dexamethasone in patients with autografted myeloma.

Ladetto M, Pagliano G, Ferrero S, Cavallo F, Drandi D, Santo L, Crippa C, De Rosa L, Pregno P, Grasso M, Liberati AM, Caravita T, Pisani F, Guglielmelli T, Callea V, Musto P, Cangialosi C, Passera R, Boccadoro M, Palumbo A.

J Clin Oncol. 2010 Apr 20;28(12):2077-84. doi: 10.1200/JCO.2009.23.7172. Epub 2010 Mar 22.

PMID:
20308672
30.

Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

Palumbo A, Gay F, Falco P, Crippa C, Montefusco V, Patriarca F, Rossini F, Caltagirone S, Benevolo G, Pescosta N, Guglielmelli T, Bringhen S, Offidani M, Giuliani N, Petrucci MT, Musto P, Liberati AM, Rossi G, Corradini P, Boccadoro M.

J Clin Oncol. 2010 Feb 10;28(5):800-7. doi: 10.1200/JCO.2009.22.7561. Epub 2010 Jan 4. Erratum in: J Clin Oncol. 2010 May 1;28(13):2314.

PMID:
20048187
31.

Pulmonary calciphylaxis and metastatic calcification with acute respiratory failure in multiple myeloma.

Crippa C, Ferrari S, Drera M, Tardanico R, Ungari M, Facchetti F, Cancarini G, Rossi G.

J Clin Oncol. 2010 Mar 20;28(9):e133-5. doi: 10.1200/JCO.2009.25.1587. Epub 2010 Jan 4. No abstract available.

PMID:
20048175
32.

A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma.

Galli M, Salmoiraghi S, Golay J, Gozzini A, Crippa C, Pescosta N, Rambaldi A.

Ann Hematol. 2010 Feb;89(2):185-90. doi: 10.1007/s00277-009-0793-8. Epub 2009 Jul 25.

PMID:
19633847
33.

Percutaneous compression plating versus gamma nail for the treatment of pertrochanteric hip fractures.

Giancola R, Antonini G, Delle Rose G, Crippa C.

Strategies Trauma Limb Reconstr. 2008 Apr;3(1):9-14. doi: 10.1007/s11751-008-0032-1. Epub 2008 Mar 29.

34.

Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.

Re A, Ferrari S, Frata P, Pizzocaro C, Crippa C, Tucci A, Facchetti F, Grazioli L, Magrini SM, Rossi G.

Ann Oncol. 2008 May;19(5):951-7. doi: 10.1093/annonc/mdm596. Epub 2008 Jan 21.

PMID:
18209012
35.

Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network.

Palumbo A, Falco P, Corradini P, Falcone A, Di Raimondo F, Giuliani N, Crippa C, Ciccone G, Omedè P, Ambrosini MT, Gay F, Bringhen S, Musto P, Foà R, Knight R, Zeldis JB, Boccadoro M, Petrucci MT; GIMEMA--Italian Multiple Myeloma Network.

J Clin Oncol. 2007 Oct 1;25(28):4459-65. Epub 2007 Sep 4.

PMID:
17785703
36.

Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma.

Galli M, Nicolucci A, Valentini M, Belfiglio M, Delaini F, Crippa C, Barbui AM, Giussani U, Rambaldi A, Barbui T.

Haematologica. 2005 Dec;90(12):1643-9.

37.

Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).

Todeschini G, Tecchio C, Pasini F, Benedetti F, Cantini M, Crippa C, Draisci M, Pizzolo G.

Cancer. 2005 Aug 1;104(3):555-60.

38.

The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis.

Tucci A, Motta M, Ungari M, Ruggeri G, Crippa C, Borlenghi E, Ubiali A, Facchetti F, Rossi G.

Haematologica. 2005 Mar;90(3):348-52.

39.

Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma.

Galli M, Elice F, Crippa C, Comotti B, Rodeghiero F, Barbui T.

Haematologica. 2004 Sep;89(9):1141-2.

Supplemental Content

Loading ...
Support Center